A new approach to dose escalation in non–small-cell lung cancer
- 1 January 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 49 (1) , 23-33
- https://doi.org/10.1016/s0360-3016(00)01374-2
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsLung Cancer, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- TomotherapySeminars in Radiation Oncology, 1999
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapyClinical Oncology, 1996
- The continual reassessment method in cancer phase i clinical trials: A simulation studyStatistics in Medicine, 1993
- Localized adenocarcinoma of the lung: A retrospective study of 186 non-metastatic patients from the french federation of cancer institutes—the radiotherapy cooperative groupInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 PatientsJNCI Journal of the National Cancer Institute, 1991
- The linear-quadratic formula and progress in fractionated radiotherapyThe British Journal of Radiology, 1989
- Repair in mouse lung for up to 20 fractions of X rays or neutronsThe British Journal of Radiology, 1985